• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能变化对肾切除及血栓切除术后伴有肿瘤血栓的肾细胞癌患者的影响:中国大型中心经验

The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience.

作者信息

Liu Zhuo, Tang Shiying, Tian Xiaojun, Zhang Hongxian, Wang Guoliang, Zhang Shudong, Ma Lulin

机构信息

Department of Urology, Peking University Third Hospital, 49 North Garden Rd., Haidian District, Beijing, People's Republic of China.

出版信息

BMC Cancer. 2020 Jan 28;20(1):61. doi: 10.1186/s12885-020-6563-7.

DOI:10.1186/s12885-020-6563-7
PMID:31992244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6986031/
Abstract

BACKGROUND

To explore the influencing factors of perioperative renal function change and their relationship with prognosis on renal cell carcinoma (RCC) patients with tumor thrombus after nephrectomy and thrombectomy.

METHODS

The clinical and pathological data of 135 patients with RCC and tumor thrombus, who underwent nephrectomy and thrombectomy at Peking University Third Hospital from May 2015 to July 2018, was retrospectively analyzed. Absolute change in estimated glomerular filtration rate (eGFR) (ACE) and percent change in eGFR (PCE) were calculated by preoperative and postoperative renal function. Linear regression analysis was used to explore the influencing factors of ACE and PCE, and logistic regression analysis was used to explore the influencing factors of worse postoperative renal function [eGFR≤60 mL/(min × 1.73 m^2)]. Cancer-specific survival (CSS) was estimated by Kaplan-Meier method and multivariate Cox regression, which were used to explore the effect of ACE and PCE on prognosis.

RESULTS

Of all the 135 patients, 101 patients (74.8%) were male and 34 patients (25.2%) were female. The mean preoperative eGFR was 73.9 ± 21.8 mL/(min × 1.73 m^2) and postoperative eGFR was 69.5 ± 25.2 mL/(min × 1.73 m^2). In multivariate linear regression analysis, preoperative eGFR (P < 0.001) and pathological type (P = 0.038) were significant predictive factors of ACE. In aspect of PCE, preoperative eGFR (P < 0.001) and pathological type (P = 0.002) were significant predictors. In multivariate logistic regression analysis, preoperative eGFR (P = 0.016) was the only risk factor of predicting worse postoperative renal function. During follow-up, 22 patients (16.3%) were dead due to RCC. According to ROC analysis, the cut off value of ACE and PCE was 13.9 and 0.16, respectively. ACE> 13.9 and PCE > 0.16 indicated worse CSS (P = 0.006 and P = 0.047, respectively). However, in multivariate Cox regression analysis of several related factors, perinephric tissues invasion (P = 0.001), sarcomatoid differentiation (P = 0.001) and ACE> 13.9 (P = 0.002) were significant prognostic factors for CSS. PCE > 0.16 seemed to be not (P = 0.055).

CONCLUSION

We explored several clinicopathological risk factors of predicting renal function change and their relationship with prognosis of RCC patients with tumor thrombus after nephrectomy and thrombectomy. The renal function change, which was associated with preoperative eGFR and pathological type, was prognostic risk factor for CSS and ACE> 13.9 indicated the worse prognosis.

摘要

背景

探讨肾细胞癌(RCC)合并肿瘤血栓患者肾切除及血栓清除术后围手术期肾功能变化的影响因素及其与预后的关系。

方法

回顾性分析2015年5月至2018年7月在北京大学第三医院接受肾切除及血栓清除术的135例RCC合并肿瘤血栓患者的临床和病理资料。根据术前和术后肾功能计算估计肾小球滤过率(eGFR)的绝对变化(ACE)和eGFR的百分比变化(PCE)。采用线性回归分析探讨ACE和PCE的影响因素,采用逻辑回归分析探讨术后肾功能恶化[eGFR≤60 mL/(min·1.73 m²)]的影响因素。采用Kaplan-Meier法和多因素Cox回归估计癌症特异性生存(CSS),并探讨ACE和PCE对预后的影响。

结果

135例患者中,男性101例(74.8%),女性34例(25.2%)。术前eGFR平均为73.9±21.8 mL/(min·1.73 m²),术后eGFR为69.5±25.2 mL/(min·1.73 m²)。多因素线性回归分析显示,术前eGFR(P<0.001)和病理类型(P = 0.038)是ACE的显著预测因素。在PCE方面,术前eGFR(P<0.001)和病理类型(P = 0.002)是显著预测因素。多因素逻辑回归分析显示,术前eGFR(P = 0.016)是预测术后肾功能恶化的唯一危险因素。随访期间,22例(16.3%)患者死于RCC。根据ROC分析,ACE和PCE的截断值分别为13.9和0.16。ACE>13.9和PCE>0.16提示CSS较差(分别为P = 0.006和P = 0.047)。然而,在对多个相关因素的多因素Cox回归分析中,肾周组织侵犯(P = 0.001)、肉瘤样分化(P = 0.001)和ACE>13.9(P = 0.002)是CSS的显著预后因素。PCE>0.16似乎不是(P = 0.055)。

结论

我们探讨了肾切除及血栓清除术后RCC合并肿瘤血栓患者预测肾功能变化的几个临床病理危险因素及其与预后的关系。与术前eGFR和病理类型相关的肾功能变化是CSS的预后危险因素,ACE>13.9提示预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4903/6986031/9650bc3e3669/12885_2020_6563_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4903/6986031/9650bc3e3669/12885_2020_6563_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4903/6986031/9650bc3e3669/12885_2020_6563_Fig1_HTML.jpg

相似文献

1
The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience.肾功能变化对肾切除及血栓切除术后伴有肿瘤血栓的肾细胞癌患者的影响:中国大型中心经验
BMC Cancer. 2020 Jan 28;20(1):61. doi: 10.1186/s12885-020-6563-7.
2
Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.中国肾细胞癌伴静脉瘤栓延伸患者的临床和肿瘤学结局:单中心经验
World J Surg Oncol. 2015 Feb 4;13:14. doi: 10.1186/s12957-015-0448-2.
3
Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.肾细胞癌合并肿瘤栓患者行肾切除术和血栓切除术时阳性淋巴结的预后价值。
Urol Int. 2021;105(7-8):657-665. doi: 10.1159/000514057. Epub 2021 Apr 21.
4
Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.术前转移状态、血栓水平和体重指数可预测接受肾切除术和下腔静脉血栓切除术的患者的总生存率。
BJU Int. 2012 Dec;110(11 Pt B):E470-4. doi: 10.1111/j.1464-410X.2012.11155.x. Epub 2012 Apr 23.
5
Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.韩国肾细胞癌伴静脉瘤栓患者的预后因素:新 2009 年 TNM 分期系统的应用。
Int Braz J Urol. 2013 May-Jun;39(3):353-63. doi: 10.1590/S1677-5538.IBJU.2013.03.08.
6
Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.国际肾细胞癌-静脉血栓形成联盟多机构分析:肾细胞癌合并肿瘤栓子患者肾静脉或下腔静脉镜下壁侵犯对癌症特异性生存的影响。
Eur Urol Focus. 2018 Apr;4(3):435-441. doi: 10.1016/j.euf.2017.01.009. Epub 2017 Feb 9.
7
Nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma among patients with impaired renal function: defining predictors of outcomes.肾功能受损患者肾细胞癌的肾切除术及下腔静脉血栓切除术:确定预后的预测因素
ANZ J Surg. 2016 Jan-Feb;86(1-2):44-8. doi: 10.1111/ans.13272. Epub 2015 Sep 15.
8
Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.组织学亚型对伴有肿瘤栓的肾细胞癌患者的癌症特异性生存的影响。
Eur Urol. 2014 Sep;66(3):577-83. doi: 10.1016/j.eururo.2013.06.048. Epub 2013 Jul 10.
9
Predictors of Postoperative Complications in Patients Who Undergo Radical Nephrectomy and IVC Thrombectomy: A Large Contemporary Tertiary Center Analysis.接受根治性肾切除术和下腔静脉血栓切除术患者术后并发症的预测因素:一项大型当代三级中心分析
Clin Genitourin Cancer. 2016 Feb;14(1):89-95. doi: 10.1016/j.clgc.2015.09.007. Epub 2015 Sep 25.
10
Surgical complexity and prognostic outcome of small volume renal cell carcinoma with high-level venous tumor thrombus and large volume renal cell carcinoma with low-level thrombus.小体积伴高水平静脉瘤栓肾细胞癌和大体积伴低水平瘤栓肾细胞癌的手术复杂性和预后结局。
Chin Med J (Engl). 2019 Aug 5;132(15):1780-1787. doi: 10.1097/CM9.0000000000000352.

引用本文的文献

1
Risk factors for renal insufficiency and survival implications after radical nephrectomy and thrombectomy in renal cell carcinoma with tumor thrombus: a systematic review.肾细胞癌伴肿瘤血栓患者根治性肾切除术和血栓切除术后肾功能不全的危险因素及生存影响:一项系统评价
BMC Urol. 2025 Jan 31;25(1):20. doi: 10.1186/s12894-024-01664-9.
2
Major Perioperative Cardiac Risk Assessment: A Review for Cardio-Oncologists and Perioperative Physicians.围手术期主要心脏风险评估:给心脏肿瘤学家和围手术期医生的综述
Clin Pract. 2024 May 17;14(3):906-914. doi: 10.3390/clinpract14030071.
3
Laparoscopic conversion to open surgery in radical nephrectomy and tumor thrombectomy: causal analysis, clinical characteristics, and treatment strategies.

本文引用的文献

1
Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study.根治性肾切除术治疗肾癌的长期肾功能恢复:一项多中心确认性研究的结果。
J Urol. 2018 Apr;199(4):921-926. doi: 10.1016/j.juro.2017.10.027. Epub 2017 Oct 21.
2
External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy.外验证接触面积作为预测部分肾切除术患者术后肾功能的指标。
J Urol. 2018 Mar;199(3):649-654. doi: 10.1016/j.juro.2017.09.070. Epub 2017 Sep 20.
3
Renal Mass and Localized Renal Cancer: AUA Guideline.
腹腔镜根治性肾切除术和肿瘤栓子切除术中转开放手术:病因分析、临床特征和治疗策略。
BMC Surg. 2020 Aug 13;20(1):185. doi: 10.1186/s12893-020-00845-1.
4
A modified surgical technique of shortening renal ischemia time in left renal cancer patients with Mayo level II-IV tumor thrombus.一种用于缩短梅奥分级II-IV级肿瘤血栓的左肾癌患者肾缺血时间的改良手术技术。
BMC Surg. 2020 Jun 5;20(1):120. doi: 10.1186/s12893-020-00769-w.
肾脏肿块和局限性肾细胞癌:AUA 指南。
J Urol. 2017 Sep;198(3):520-529. doi: 10.1016/j.juro.2017.04.100. Epub 2017 May 4.
4
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.《2016 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类-第 B 部分:前列腺和膀胱肿瘤》。
Eur Urol. 2016 Jul;70(1):106-119. doi: 10.1016/j.eururo.2016.02.028. Epub 2016 Mar 17.
5
Recovery of renal function after radical nephrectomy and risk factors for postoperative severe renal impairment: A Japanese multicenter longitudinal study.根治性肾切除术后肾功能的恢复及术后严重肾功能损害的危险因素:一项日本多中心纵向研究。
Int J Urol. 2016 Mar;23(3):219-23. doi: 10.1111/iju.13028. Epub 2015 Dec 10.
6
Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level.根治性肾切除术和血栓切除术治疗肾细胞癌合并静脉瘤栓患者的预后结果及危险因素:静脉瘤栓水平的预后意义
Biomed Res Int. 2015;2015:163423. doi: 10.1155/2015/163423. Epub 2015 Sep 3.
7
Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy.实质体积评估作为一种预测工具,用于确定保留肾单位手术与根治性肾切除术相比对肾功能的益处。
J Endourol. 2016 Jan;30(1):114-21. doi: 10.1089/end.2015.0411. Epub 2015 Sep 25.
8
Annual report on status of cancer in China, 2011.《2011年中国癌症现状年度报告》
Chin J Cancer Res. 2015 Feb;27(1):2-12. doi: 10.3978/j.issn.1000-9604.2015.01.06.
9
EAU guidelines on renal cell carcinoma: 2014 update.EAU 指南:肾细胞癌. 2014 年更新版.
Eur Urol. 2015 May;67(5):913-24. doi: 10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21.
10
Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology.肾功能不全与乳头状肾细胞癌组织学类型的风险增加相关。
Int Urol Nephrol. 2014 Nov;46(11):2127-32. doi: 10.1007/s11255-014-0780-4. Epub 2014 Jul 8.